General Information
Innocoll Diabetic Foot Ulcer INN-TOP-004
A Phase 3 Randomized, Placebo-Controlled, Blinded Study to Investigate the Safety and Efficacy of a Topical Gentamicin-Collagen Sponge in Combination with Systemic Antibiotic Therapy in Diabetic Patients with and Infected Foot Ulcer
| Protocol | INN-TOP-004 |
|---|---|
| Identifier | Site No: 840-151 |
| UID | a3d3c9dc-adf0-42bd-8951-14e73e6e92a6 |
| Status | Done - Archived |
| Phase | 3 |
| Category | Diabetic Foot Ulcer / Adult |
| Launch Year | 2015 |
| NCT Number | - |
| Created | 2015-05-06 16:54 |
| Last Updated | 2015-05-06 16:54 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | No | |
| Enrollment Open | No | |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2015-07-30 | No |
| PI Meeting Start | 2015-06-04 | No |
| PI Meeting End | 2015-06-05 | No |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | 2016-12-01 | No |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | - | No | |
| Recruiter | - | No | |
| Coordinator | Rocha, Luis | LRocha | No |
| Regulatory | Aguirre, Sandra | SAguirre | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | Innocoll Pharmaceuticals |
|---|---|
| Division | Innocoll Pharmaceuticals |
| Team | Innocoll Pharmaceuticals |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | MED1-15-134 |
|---|---|
| CRO | Medpace, Inc. |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gainsboro |
| Currency | - |
